($) NZD
  • ($) USD (Default)
  • ($) AUD
  • (€) EUR
  • ($) CAD
  • (£) GBP

BPC-157 And Thymosin Beta-4 Capsules

$366.67

The synergistic blend of BPC-157 and Thymosin Beta-4 capsules delivers extraordinary advantages, such as accelerating healing, enhancing tissue repair and muscle development, while also contributing to the reduction of inflammation and bolstering immune system recovery.

 

– 60 CAPSULES Per Bottle | 500mcg BPC-157 & 500mcg Thymosin Beta 4 Per Capsule –

441 in stock

441 in stock

First time customer gets 15% discount code = 1storder

BPC-157 And Thymosin Beta-4 Capsules New Zealand

BPC-157 and Thymosin Beta-4 capsules are at the forefront of peptide research, combining two highly studied peptides in an easy-to-use oral form. BPC Arginate Salt is known for its healing effects on tendons, ligaments, and the gastrointestinal tract. Thymosin Beta-4 (TB-500) is recognized for its strong healing, anti-inflammatory, and regenerative properties, particularly in soft tissue repair and immune system support.

Their combined use offers a comprehensive healing and recovery strategy. When encapsulated, these peptides are protected through digestion, ensuring their effectiveness in the body.

The combination in capsule form simplifies administration, potentially increasing compliance among study participants and making it an attractive option for research into a broad range of therapeutic applications. This novel formulation opens new avenues for exploring the combined effects of BPC-157 and TB-500 on healing, recovery, and overall health improvement in both clinical settings and research studies.

For detailed insights into the specific benefits of each peptide, their scientific structure, and the product formats available, please visit their respective pages: the BPC-157 Category Page and the TB-500 Category Page.


BPC-157 And Thymosin Beta-4 Capsules Benefits

  • Enhanced Healing Processes: The synergy between BPC-157 and Thymosin Beta-4 accelerates the healing of tendons, ligaments, and muscle tissue, making it particularly beneficial for individuals recovering from injuries or surgeries.
  • Anti-inflammatory Action: This BPC-157 and Thymosin Beta-4 Capsules combination exhibits potent anti-inflammatory properties, reducing swelling and discomfort in injured or inflamed tissues and thus, facilitating a quicker recovery.
  • Immune System Support: Thymosin Beta-4 is known for its ability to modulate the immune system, enhancing the body’s ability to defend against infections and diseases.
  • Improved Gastrointestinal Health: BPC-157’s targeted action on the gastrointestinal tract helps in healing ulcers, inflammation, and other digestive system disorders, offering a comprehensive approach to gut health.
  • Systemic Benefits for Overall Health: Beyond the BPC-157 and Thymosin Beta-4 Capsules localized healing effects, these peptides work systemically to improve overall health and wellbeing, underscoring their potential in preventative health strategies.
  • Simplified Administration: The oral form of these combined peptides, BPC-157 and Thymosin Beta-4 Capsules, makes the administration process straightforward and non-invasive, likely increasing adherence in research subjects and patients alike.
  • Versatility in Research and Clinical Applications: The broad spectrum of therapeutic effects opens up numerous avenues for research into their potential uses across various medical disciplines and treatment protocols.

New Zealand Direct Sarms offers a number of encapulated peptides for research purposes, featuring GHK-Cu Capsules. These can enhance the effects of both BPC-157 and Thymosin Beta-4 peptides, aiding in healing and repair processes.


References:

[1] N.Kumar and C.Yin (2018) The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases – Pharmacological Research, Volume 134, August 2018, Pages 268-279.

[2] P.Sikiric et al (2016) Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications – Current Neuropharmacology, 2016 Nov; 14(8): 857–865.


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

Related Products

You may also like…